BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 26293775)

  • 1. Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology.
    Xu P; Wang L; Huang L; Li W; Lv S; Lv M; Ma J; Zhou Q; Wu X; Fu Z; Lu C; Yin H
    Biomed Pharmacother; 2015 Oct; 75():173-8. PubMed ID: 26293775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of microRNAs expressed in human breast cancer T-47D cells in response to prolactin treatment by Solexa deep-sequencing technology.
    Wei Q; He W; Yao J; Guo L; Lu Y; Cao X
    Biochem Biophys Res Commun; 2013 Mar; 432(3):480-7. PubMed ID: 23410749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
    Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
    Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.
    Zhou S; Li J; Xu H; Zhang S; Chen X; Chen W; Yang S; Zhong S; Zhao J; Tang J
    Gene; 2017 Jul; 622():1-12. PubMed ID: 28431975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
    Tormo E; Pineda B; Serna E; Guijarro A; Ribas G; Fores J; Chirivella E; Climent J; Lluch A; Eroles P
    J Cell Biochem; 2015 Sep; 116(9):2061-73. PubMed ID: 25802200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
    Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
    Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
    Zhong S; Li W; Chen Z; Xu J; Zhao J
    Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression profiling and bioinformatics analysis of dysregulated microRNAs in vinorelbine-resistant breast cancer cells.
    Zhong S; Ma T; Zhang X; Lv M; Chen L; Tang J; Zhao J
    Gene; 2015 Feb; 556(2):113-8. PubMed ID: 25445394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.
    Boo L; Ho WY; Ali NM; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Ong HK; Cheong SK
    Int J Biol Sci; 2016; 12(4):427-45. PubMed ID: 27019627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells.
    Chen WX; Xu LY; Qian Q; He X; Peng WT; Zhu YL; Cheng L
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30201690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
    Wang ZX; Lu BB; Wang H; Cheng ZX; Yin YM
    Arch Med Res; 2011 May; 42(4):281-90. PubMed ID: 21820606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of microRNAs from Chinese pollination constant non-astringent persimmon using high-throughput sequencing.
    Luo Y; Zhang X; Luo Z; Zhang Q; Liu J
    BMC Plant Biol; 2015 Jan; 15():11. PubMed ID: 25604351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes.
    Zhang J; Zhang HD; Yao YF; Zhong SL; Zhao JH; Tang JH
    Cell Physiol Biochem; 2015; 36(6):2274-86. PubMed ID: 26279432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1.
    Li XJ; Ji MH; Zhong SL; Zha QB; Xu JJ; Zhao JH; Tang JH
    Arch Med Res; 2012 Oct; 43(7):514-21. PubMed ID: 23085450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1.
    Yang X; Hu Q; Hu LX; Lin XR; Liu JQ; Lin X; Dinglin XX; Zeng JY; Hu H; Luo ML; Yao HR
    Discov Med; 2017 Sep; 24(131):75-85. PubMed ID: 28972876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer.
    Xu M; Chen S; Yang W; Cheng X; Ye Y; Mao J; Wu X; Huang L; Ji J
    Cell Physiol Biochem; 2018; 47(1):151-160. PubMed ID: 29763898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of microRNA in drug-resistant breast cancer cell line MCF-7/ADR].
    Cui XY; Guo YJ; Yao HR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1813-5. PubMed ID: 18971180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.